Matches in Wikidata for { <http://www.wikidata.org/entity/Q97046062> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q97046062 description "clinical trial" @default.
- Q97046062 description "ensayo clínico" @default.
- Q97046062 description "ensayu clínicu" @default.
- Q97046062 description "klinisch onderzoek" @default.
- Q97046062 description "клінічне випробування" @default.
- Q97046062 description "临床试验" @default.
- Q97046062 name "Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer" @default.
- Q97046062 name "Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer" @default.
- Q97046062 type Item @default.
- Q97046062 label "Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer" @default.
- Q97046062 label "Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer" @default.
- Q97046062 prefLabel "Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer" @default.
- Q97046062 prefLabel "Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer" @default.
- Q97046062 P1050 Q97046062-E8632116-B23E-4F43-A076-8B1487D21895 @default.
- Q97046062 P1132 Q97046062-1F5DDE70-E275-4496-8BC8-AB87F72DF4FB @default.
- Q97046062 P1476 Q97046062-82295F46-2253-4420-AEBA-C42677C16119 @default.
- Q97046062 P17 Q97046062-44BE311F-392C-4ABD-B5C4-2A4655F35A0B @default.
- Q97046062 P2899 Q97046062-AA350EA4-7E03-4B68-BDB8-1C91EA79F5CA @default.
- Q97046062 P3098 Q97046062-D3D30C71-01A4-41C9-B616-7F6BDB62E70A @default.
- Q97046062 P31 Q97046062-24D41CB8-3BCD-405C-BFC7-3D9137E9CED5 @default.
- Q97046062 P4844 Q97046062-3562D3F9-D718-4576-A6FA-6B9BBD9FA5B5 @default.
- Q97046062 P580 Q97046062-EF0FDAD8-AA47-4D06-8516-784525A7251B @default.
- Q97046062 P582 Q97046062-259A4763-9BB2-421F-A6AF-047907A05FD4 @default.
- Q97046062 P6099 Q97046062-A282C1F8-3F17-4999-B334-36A00AB98195 @default.
- Q97046062 P6153 Q97046062-D1CDDAC7-D0E5-4892-B98F-1551B1201750 @default.
- Q97046062 P767 Q97046062-4573E693-E22A-42CD-BCE7-E7905162489D @default.
- Q97046062 P8005 Q97046062-A6C3660F-2B8B-4554-B370-15DE388F86EC @default.
- Q97046062 P8363 Q97046062-52AE9557-C257-41B0-8FAA-E35CBC756743 @default.
- Q97046062 P859 Q97046062-566CB2B9-3EF6-4A3B-B974-3DB9B686A2C1 @default.
- Q97046062 P1050 Q33525 @default.
- Q97046062 P1132 "+29" @default.
- Q97046062 P1476 "A Phase 2 Trial of Cabozantinib and Pembrolizumab in the First-Line Treatment of Advanced Hepatocellular Carcinoma" @default.
- Q97046062 P17 Q30 @default.
- Q97046062 P2899 "+18" @default.
- Q97046062 P3098 "NCT04442581" @default.
- Q97046062 P31 Q30612 @default.
- Q97046062 P4844 Q13896859 @default.
- Q97046062 P580 "2020-08-01T00:00:00Z" @default.
- Q97046062 P582 "2023-09-13T00:00:00Z" @default.
- Q97046062 P6099 Q42824440 @default.
- Q97046062 P6153 Q219563 @default.
- Q97046062 P767 Q664846 @default.
- Q97046062 P8005 Q76649614 @default.
- Q97046062 P8363 Q78089383 @default.
- Q97046062 P859 Q219563 @default.